Outcomes of relapse in patients with deferred autologous stem cell transplant after achieving at least very good partial response following bortezomib, adriamycin, dexamethasone chemotherapy for newly diagnosed multiple myeloma in the phase II PADIMAC trial
- Publication date
- 1 February 2022
- Publisher
- 'Royal College of Obstetricians & Gynaecologists (RCOG)'